PRMT5 and neoplasm: Transcriptional heterogeneity was observed in B cells between samples; noting that PRMT5 was not abundantly expressed in all B cells, but was instead restricted to distinct subpopulations also displaying strong MYC and MKI67 expression (Supplemental Fig. 1F), indicative of a highly proliferative population within the overall tumor burden.